Production

Hetero Drugs established in the year 1993, with the motto to be the best in the API manufacturing, Hetero today embodies the vision of a top notch player in developing and commercialising products catering to a variety of therapeutic categories, integrating into a leading finished dosage manufacturer.

True to the Statement, "Where the Future Started Yesterday", with a foresight on the current trends in the Pharmaceutical Market, Hetero has grown from strength to strength, combining its Research Strengths, Manufacturing Capabilities ,Human Resources and well established quality management system

Client of SS Consultancy

Post: Qc chemists

SYNTHOKEM LABS PRIVATE LIMITED is a manufacturer of Active Pharmaceutical Ingredients and drug intermediates, located in Hyderabad, INDIA.Our commitment lies in providing the required quality API's and Intermediates to our exacting customers worldwide. We cater to a cross section of clients in Asia, Europe, North and South America.Our inherent strength lies in producing cutting edge intermediates, for new as well as off patent API's within the requisite time frame stipulated by our customers. Fifty percent of our business has evolved from custom synthesis projects, which start from gram level and rise to multi ton supplies.

Hetero Drugs established in the year 1993, with the motto to be the best in the API manufacturing, Hetero today embodies the vision of a top notch player in developing and commercialising products catering to a variety of therapeutic categories, integrating into a leading finished dosage manufacturer.
True to the Statement, "Where the Future Started Yesterday", with a foresight on the current trends in the Pharmaceutical Market, Hetero has grown from strength to strength, combining its Research Strengths, Manufacturing Capabilities ,Human Resources and well established quality management system.

Post: PRODUCTION/PACKING(FORMULATION DIVISION)

FDC carries forward the flaming spirit of its first dream, achieving accreditations from the US-FDA, UK-MHRA, MCC-RSA, and the UAE, to cite a few. FDC is a forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmics. FDC has also set-up globally approved, multi-location manufacturing facilities for Active Pharmaceuticals Ingredients (APIs) as well as Finished Dosage Forms. These facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh. FDC markets more than 300 products in India and exports many of these to over 50 countries.

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. We are looking suitable candidates for below openings at our flagship formulation facility located at Paithan Aurangabad, which is approved by the US FDA, UK MHRA. It also holds WHO pre- qualification.

Ipca is a fully integrated, rapidly growing Indian pharmaceutical company with a strong thrust on exports. Ipca's APIs and Formulations produced at worldclass manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA). With operations in over 100 countries, exports account for over 52%  of the company's income.

A leading Group with global presence and approvals from EU-GMP. MHRA-UK. ANV1SA Brazil. PIC'S Ukraine. WHO Geneva. INVIMA Columbia. USFDA - 2018. Exposure of working with Regulatory Approved facilities will be desired. For our Sterile (Liquid injectables/Lyophilized Vials) manufacturing facility at Baddi (HP), we are conducting Walk-in Interview on plant for following positions

Posts : Executive/ Officer/ Operator

AstraZeneca contributes meaningfully to the UK beyond the provision of our medicines and the benefits they provide to the health of the nation. We commissioned a report in 2009 to measure our significant investment to the UK economy, which includes investment in jobs and wealth creation. Oxera, an independent economic consultancy provided the analysis for this report.

Post : Associate Pharma Production